Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP909432.RA5j6ARnd-VN-h0357EefNnnJKz7t31BxbVqYIDi3cqPQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP909432.RA5j6ARnd-VN-h0357EefNnnJKz7t31BxbVqYIDi3cqPQ130_assertion type Assertion NP909432.RA5j6ARnd-VN-h0357EefNnnJKz7t31BxbVqYIDi3cqPQ130_head.
- NP909432.RA5j6ARnd-VN-h0357EefNnnJKz7t31BxbVqYIDi3cqPQ130_assertion description "[Targeting PAR(1) on the pulmonary epithelium may offer a unique opportunity for therapeutic intervention in pulmonary fibrosis and other inflammatory and fibroproliferative conditions associated with excessive local generation of thrombin and CCL2 release.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP909432.RA5j6ARnd-VN-h0357EefNnnJKz7t31BxbVqYIDi3cqPQ130_provenance.
- NP909432.RA5j6ARnd-VN-h0357EefNnnJKz7t31BxbVqYIDi3cqPQ130_assertion evidence source_evidence_literature NP909432.RA5j6ARnd-VN-h0357EefNnnJKz7t31BxbVqYIDi3cqPQ130_provenance.
- NP909432.RA5j6ARnd-VN-h0357EefNnnJKz7t31BxbVqYIDi3cqPQ130_assertion SIO_000772 19060230 NP909432.RA5j6ARnd-VN-h0357EefNnnJKz7t31BxbVqYIDi3cqPQ130_provenance.
- NP909432.RA5j6ARnd-VN-h0357EefNnnJKz7t31BxbVqYIDi3cqPQ130_assertion wasDerivedFrom befree-20140225 NP909432.RA5j6ARnd-VN-h0357EefNnnJKz7t31BxbVqYIDi3cqPQ130_provenance.
- NP909432.RA5j6ARnd-VN-h0357EefNnnJKz7t31BxbVqYIDi3cqPQ130_assertion wasGeneratedBy ECO_0000203 NP909432.RA5j6ARnd-VN-h0357EefNnnJKz7t31BxbVqYIDi3cqPQ130_provenance.